Trial
NCT02083666
Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Swedish Orphan Biovitrum
Collaborators
Richmond Pharmacology Limited
Condition
Healthy
Intervention
SOBI002
Why stopped
Transient adverse events observed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-07-28